510 SAMHSA-listed treatment centers in New Jersey. Free, confidential help available 24/7.
Browse 510 verified drug and alcohol treatment facilities in New Jersey. Each listing is sourced from federal databases and verified for accuracy. Use the information below to compare programs, verify insurance acceptance, and find the right facility for your needs.
Need help choosing? Call for free, confidential guidance from a treatment specialist.
Drug-overdose mortality in New Jersey reached 30.1 per 100k in the most recent CDC dataset, which is below the US baseline of 32.6. Treatment options on this page range from short-stay medical detox to multi-month residential to flexible outpatient care, all from federally-credentialed providers.
Listings are sourced from the federal SAMHSA treatment locator and updated quarterly against state licensing-board records. No pay-for-placement.
A treatment program in New Jersey is a starting block, not a finish line. Sustained recovery comes from what happens in the 12 months after discharge — outpatient continuation, sober living, mutual-support groups, MAT continuation if applicable, peer-recovery support.
Maintenance outpatient therapy following IOP/PHP discharge: weekly individual sessions, monthly medication review, monthly group if needed. Often Medicaid-covered.
A drug-free environment with house rules, peer accountability, and employment expectations. Sober living can be 30 days to 12+ months. Check NARR certification.
Peer support groups are the longest-running aftercare modality. AA and NA are most common; SMART Recovery, LifeRing, and Refuge Recovery offer secular/cognitive alternatives.
Long-term MAT for opioid-use disorder reduces overdose mortality. Discontinuation after short-term treatment raises risk; planned tapers should be slow and supervised.
Lived-experience navigators with state certification. Particularly effective for newcomers to recovery navigating employment, housing, and court-system involvement.
Narcan (naloxone) is the overdose-reversal medication. Available without prescription at New Jersey pharmacies and from many harm-reduction organizations. Train your inner circle.
The first 90 days post-discharge are highest-risk. Daily community contact, scheduled therapy/coaching, MAT continuity, written relapse-response plan.
Effective addiction treatment in New Jersey blends multiple evidence-based modalities — there is no single "best" therapy. The cards below describe the six approaches most commonly used in state-licensed facilities.
Patients learn to map triggers, cravings, and use into a chain that can be interrupted at multiple points. Skills-based rather than insight-based.
A counseling style, not a manualized therapy. MI principles inform many evidence-based addiction protocols, especially in induction phases.
Combines pharmacology and counseling. The strongest evidence base in addiction medicine — particularly for opioid and alcohol use disorders.
DBT teaches four skill sets: mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness. All apply to addiction recovery.
About half of people entering addiction treatment also meet criteria for a trauma-related diagnosis. Specific therapies (EMDR, CPT, Seeking Safety) address both.
No single mutual-support framework works for everyone. New Jersey facilities now typically introduce 2–3 options during treatment so patients can choose what fits.
Under the federal Mental Health Parity and Addiction Equity Act, most insurance plans in New Jersey must cover substance-use treatment at parity with physical-health benefits.
Aetna · Anthem · Blue Cross Blue Shield · Cigna · Humana · Kaiser Permanente · UnitedHealthcare · Medicare · NJ FamilyCare · Tricare (military) · VA Community Care
In New Jersey, Medicaid is administered as NJ FamilyCare. State-licensed facilities are typically required to accept it for substance-use treatment. Verify eligibility at medicaid.gov.
Addiction is a family disease. New Jersey treatment centers increasingly include family programming because it materially improves treatment retention and post-discharge relapse rates.
In New Jersey, the gap between deciding to seek treatment and beginning treatment is most commonly 3–5 days. Faster admissions happen at facilities with on-call medical staff for detox; slower ones occur when Medicaid eligibility or out-of-network benefits need to be sorted first.
Roughly 11–14% of New Jersey residents are uninsured. The good news: every state, including New Jersey, has multiple pathways to substance-use treatment for people without insurance. The hard part is navigating which to use; the options below cover most situations.
| Level | Duration | OOP (insured) | Best fit |
|---|---|---|---|
| Medical detox | 3–7 days | $0–$3,000 | Severe alcohol/opioid withdrawal |
| Residential / Inpatient | 28–90 days | $0–$10,000 | Moderate-to-severe addiction, 24/7 structure needed |
| Partial Hospitalization (PHP) | 2–6 weeks | $0–$5,000 | 20+ hrs/wk structured care |
| Intensive Outpatient (IOP) | 8–12 weeks | $0–$2,500 | 9–19 hrs/wk, fits work/school |
| Standard Outpatient | 3–12+ months | $0–$1,500 | Aftercare or mild dependence |
The shift to population-specific addiction treatment in New Jersey has accelerated in the post-MHPAEA period. Veterans, adolescents, women, LGBTQ+ patients, and healthcare professionals each have evidence-backed reasons to seek targeted programming.
Trauma-informed care, pregnancy-aware medical management, parenting groups.
Emotion-regulation focus, anger management, fatherhood support, identity processing.
School integration, family therapy required, lower-intensity longer-duration models.
Combat-trauma-aware programming, VA Community Care eligibility, military culture competence.
Identity-affirming therapy, anti-discrimination policies, family-of-choice integration.
Psychiatry on staff, integrated treatment of depression/anxiety/PTSD/bipolar alongside substance use.
Nursing/physician recovery monitoring, confidential reporting, return-to-practice protocols.
Late-onset alcohol-use disorder, polypharmacy concerns, age-appropriate group composition.
All statistics and policy claims sourced from federal-government and peer-reviewed agencies. Last verified May 2026.
This section covers state-level context for addiction treatment in New Jersey: how the clinical continuum is structured, what federal resources are available, how insurance works in practice, and what evidence-based approaches apply to different substances and populations. The goal is to equip you to navigate New Jersey treatment options effectively, whether you're researching for yourself or a family member.
Federal authority for addiction treatment policy in New Jersey flows through SAMHSA (Substance Abuse and Mental Health Services Administration), which sets standards, maintains the national treatment locator, operates the 988 Suicide & Crisis Lifeline, and administers block grants to state agencies. CMS (Centers for Medicare & Medicaid Services) governs insurance coverage for federally funded programs. The DEA regulates controlled-substance prescribing — meaningful because medication-assisted treatment for opioid use disorder operates under specific DEA waivers and reporting requirements.
Suicide risk in addiction is elevated and warrants direct attention. New Jersey residents with active suicidal ideation should contact 988 immediately, present to an emergency department, or call a mental-health crisis mobile team if available locally. Family members concerned about a loved one's suicide risk can also use 988 for guidance; operators are trained in third-party crisis situations. Means restriction — removing or locking up firearms, medications, and other lethal means during a crisis — reduces completed suicide.
New Jersey addiction treatment is structured around the ASAM Criteria continuum: medically managed withdrawal, residential treatment, partial hospitalization, intensive outpatient, and standard outpatient. State licensing requires that facilities providing residential and detox services maintain specific physician oversight, nursing ratios, and medical screening protocols. Patient step-down between levels follows clinical criteria, not calendar dates — meaning length of stay varies by individual response rather than a fixed program duration.
Sober living environments (SLEs) in New Jersey bridge residential treatment and full independent living. SLEs vary widely in quality and structure; the National Alliance for Recovery Residences (NARR) provides a quality-standards framework with four certification levels (peer-run to fully clinical). Reputable New Jersey SLEs require drug testing, mutual-support meeting attendance, and progressive responsibility (employment, household contribution, recovery-plan accountability). Length of stay is typically 3-12 months, longer for patients with severe addiction histories or unstable home environments.
Self-pay options for New Jersey addiction treatment include facility-direct payment plans, medical credit lines (e.g., CareCredit), 401(k) hardship withdrawals, family financing, and sliding-scale community-based programs. Some facilities offer scholarships or reduced rates for patients without insurance. Federally Qualified Health Centers in New Jersey provide outpatient addiction services on sliding-scale terms based on income. Religious-affiliated programs often have separate financial-assistance pathways.
Telehealth has expanded substance-use treatment access in New Jersey since federal and state policy changes during the COVID emergency made remote care reimbursable at parity with in-person. Outpatient counseling, MAT induction and maintenance (now permitted via telehealth for buprenorphine), and group therapy can all be delivered remotely. Telehealth is especially impactful for rural New Jersey residents and patients who cannot easily travel due to work, caregiving, or disability. Most major insurers cover telehealth addiction services at the same rate as in-person.